An Israeli company is investigating with the US military a solution to the mustard gas vulnerability

[dani191]

An Israeli company is investigating with the US military a solution to the mustard gas vulnerability
Ami Rukhas Domba 19/06/2018 Contact author

print
send to a friend
A + A-size
Share on
Share on

http://www.pluristem.com/pipeline-plx-r18/

Israeli company Pluristem Therapeutics is developing treatment for mustard gas victims together with the US military, according to the company's report to the stock exchange. According to the report, this is the company's PLX-R18 product.

"These studies will be funded by the National Institutes of Health (NIH) and mark the second project chosen by DOD for PLX-R18. The DOD also studies the effectiveness of PLX-R18 as an innovative medical anti-inflammatory device (ARS) before exposure to high levels of Which is designed to support the needs of the US armed forces. These are two projects that the DOD in addition to NIH funded in the late development stage of the PLX-R18. "
http://www.israeldefense.co.il/he/node/34664

 

[jetray]

wouldnt a hot dog with no mustard do the job?